According to the research report, the global market for Live Attenuated Japanese Encephalitis Vaccine should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.

China Live Attenuated Japanese Encephalitis Vaccine market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.

The United States Live Attenuated Japanese Encephalitis Vaccine market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.

In terms of type, 0.5ml segment holds a share about % in 2022 and will reach % in 2029; while in terms of application, Hospital has a share approximately % in 2022 and will grow at a CAGR % during 2023 and 2029.

The global key manufacturers of Live Attenuated Japanese Encephalitis Vaccine include Novartis, Sanofi, Chengdu Institute of Biological Products, Wuhan Institute of Biological Products, Lanzhou Institute of Biological Products, Beijing Temple of Heaven Biological Products, Valneva, Bharat Biotech and Cheng Da Biology, etc. In 2022, the global top five players hold a share approximately % in terms of revenue.

Epidemic Japanese encephalitis (hereinafter referred to as "JE") is an acute infectious disease of the central nervous system caused by the Japanese encephalitis virus, with inflammation of the brain parenchyma as the main lesion.

This report aims to provide a comprehensive study of the global market for Live Attenuated Japanese Encephalitis Vaccine.
Key Takeaways and Highlights

(1) Global Live Attenuated Japanese Encephalitis Vaccine market size (sales volume & revenue), history data from 2018-2022 and forecast data from 2023 to 2029.

(2) Global Live Attenuated Japanese Encephalitis Vaccine market competitive situation, sales, revenue, price and market share, from 2018 to 2022.

(3) China Live Attenuated Japanese Encephalitis Vaccine market competitive situation, sales, revenue, price and market share, from 2018 to 2022.

(4) Global Live Attenuated Japanese Encephalitis Vaccine segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.

(5) Global Live Attenuated Japanese Encephalitis Vaccine segment by type and by application and regional segment by type and by application.

(6) Global major production regions of Live Attenuated Japanese Encephalitis Vaccine, capacity, production and trends.

(7) Live Attenuated Japanese Encephalitis Vaccine industry supply chain, upstream, midstream and downstream analysis.

Regional Breakdown: Analyzing Market Segments by Geography

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)

South America (Brazil, Rest of South America)

Middle East & Africa

Segmenting by Type: Comprehensive Coverage and Analysis

0.5ml

1ml

2.5ml

Application-Based Segmentation: Unlocking Market Opportunities

Hospital

Clinic

In the Spotlight: A Closer Look at Market Players

Novartis

Sanofi

Chengdu Institute of Biological Products

Wuhan Institute of Biological Products

Lanzhou Institute of Biological Products

Beijing Temple of Heaven Biological Products

Valneva

Bharat Biotech

Cheng Da Biology

Biocelect Pty Ltd

Glovax Co., Ltd.

1 Market Overview

1.1 Live Attenuated Japanese Encephalitis Vaccine Definition

1.2 Global Live Attenuated Japanese Encephalitis Vaccine Market Size and Forecast

1.2.1 By Revenue, Global Live Attenuated Japanese Encephalitis Vaccine Market Size, 2018-2029

1.2.2 By Sales Volume, Global Live Attenuated Japanese Encephalitis Vaccine Market Size, 2018-2029

1.2.3 Global Live Attenuated Japanese Encephalitis Vaccine Price Trend, 2018-2029

1.3 China Live Attenuated Japanese Encephalitis Vaccine Market Size and Forecast

1.3.1 By Revenue, China Live Attenuated Japanese Encephalitis Vaccine Market Size, 2018-2029

1.3.2 By Sales Volume, China Live Attenuated Japanese Encephalitis Vaccine Market Size, 2018-2029

1.3.3 China Live Attenuated Japanese Encephalitis Vaccine Price Trend, 2018-2029

1.4 China Percentage in Global Market

1.4.1 By Revenue, China Live Attenuated Japanese Encephalitis Vaccine Share in Global Market, 2018-2029

1.4.2 By Sales Volume, China Live Attenuated Japanese Encephalitis Vaccine Share in Global Market, 2018-2029

1.4.3 Live Attenuated Japanese Encephalitis Vaccine Market Size: China VS Global, 2018-2029

1.5 Live Attenuated Japanese Encephalitis Vaccine Market Dynamics

1.5.1 Live Attenuated Japanese Encephalitis Vaccine Market Drivers

1.5.2 Live Attenuated Japanese Encephalitis Vaccine Market Restraints

1.5.3 Live Attenuated Japanese Encephalitis Vaccine Industry Trends

1.5.4 Live Attenuated Japanese Encephalitis Vaccine Industry Policy

2 Global Competitive Landscape by Company

2.1 Global Live Attenuated Japanese Encephalitis Vaccine Revenue by Company, 2018-2023

2.2 Global Live Attenuated Japanese Encephalitis Vaccine Sales Volume by Company, 2018-2023

2.3 Global Live Attenuated Japanese Encephalitis Vaccine Price by Company, 2018-2023

2.4 Global Live Attenuated Japanese Encephalitis Vaccine Participants, Market Position (Tier 1, Tier 2 and Tier 3)

2.5 Global Live Attenuated Japanese Encephalitis Vaccine Concentration Ratio

2.6 Global Live Attenuated Japanese Encephalitis Vaccine Mergers & Acquisitions, Expansion Plans

2.7 Global Live Attenuated Japanese Encephalitis Vaccine Manufacturers Product Type

3 China Competitive Landscape by Company

3.1 China Live Attenuated Japanese Encephalitis Vaccine Revenue by Company, 2018-2023

3.2 China Live Attenuated Japanese Encephalitis Vaccine Sales Volume by Company, 2018-2023

3.3 China Live Attenuated Japanese Encephalitis Vaccine Live Attenuated Japanese Encephalitis Vaccine Participants, Market Position (Tier 1, Tier 2 and Tier 3)

3.4 China Live Attenuated Japanese Encephalitis Vaccine Market, Sales Percentage of Local Players VS Foreign Players (2018-2023)

3.5 Chinese Local Players, Live Attenuated Japanese Encephalitis Vaccine Domestic VS Export

3.6 China Market, Live Attenuated Japanese Encephalitis Vaccine Import & Export

3.6.1 China Market, Live Attenuated Japanese Encephalitis Vaccine Import & Export, 2018-2029

3.6.2 China Live Attenuated Japanese Encephalitis Vaccine Import & Export Trends

3.6.3 Main Sources of China Live Attenuated Japanese Encephalitis Vaccine Import

3.6.4 Export Destination of China Live Attenuated Japanese Encephalitis Vaccine

4 Live Attenuated Japanese Encephalitis Vaccine Production by Region

4.1 Global Live Attenuated Japanese Encephalitis Vaccine Capacity, Production and Capacity Utilization, 2018-2029

4.2 Global Geographic Distribution of Live Attenuated Japanese Encephalitis Vaccine Manufacturers

4.3 Global Major Manufacturers, Live Attenuated Japanese Encephalitis Vaccine Capacity Expansion and Future Plans

4.4 Global Live Attenuated Japanese Encephalitis Vaccine Capacity by Region

4.5 Global Live Attenuated Japanese Encephalitis Vaccine Production by Region

4.5.1 Global Live Attenuated Japanese Encephalitis Vaccine Production & Forecast by Region, 2018 VS 2022 VS 2029

4.5.2 Global Live Attenuated Japanese Encephalitis Vaccine Production by Region, 2018-2023

4.5.3 Global Live Attenuated Japanese Encephalitis Vaccine Production Market Share & Forecast by Region, 2018-2029

5 Industry Chain Analysis

5.1 Live Attenuated Japanese Encephalitis Vaccine Industry Chain

5.2 Live Attenuated Japanese Encephalitis Vaccine Upstream Analysis

5.2.1 Live Attenuated Japanese Encephalitis Vaccine Core Raw Materials

5.2.2 Main Manufacturers of Live Attenuated Japanese Encephalitis Vaccine Core Raw Materials

5.3 Midstream Analysis

5.4 Downstream Analysis

5.5 Live Attenuated Japanese Encephalitis Vaccine Production Mode

5.6 Live Attenuated Japanese Encephalitis Vaccine Procurement Model

5.7 Live Attenuated Japanese Encephalitis Vaccine Industry Sales Model and Sales Channels

5.7.1 Live Attenuated Japanese Encephalitis Vaccine Sales Model

5.7.2 Live Attenuated Japanese Encephalitis Vaccine Typical Distributors

6 Sights by Type

6.1 Live Attenuated Japanese Encephalitis Vaccine Classification

6.1.1 0.5ml

6.1.2 1ml

6.1.3 2.5ml

6.2 By Type, Global Live Attenuated Japanese Encephalitis Vaccine Market Size & CAGR, 2018 VS 2022 VS 2029

6.3 By Type, Global Live Attenuated Japanese Encephalitis Vaccine Revenue, 2018-2029

6.4 By Type, Global Live Attenuated Japanese Encephalitis Vaccine Sales Volume, 2018-2029

6.5 By Type, Global Live Attenuated Japanese Encephalitis Vaccine Price, 2018-2029

7 Sights by Application

7.1 Live Attenuated Japanese Encephalitis Vaccine Segment by Application

7.1.1 Hospital

7.1.2 Clinic

7.2 By Application, Global Live Attenuated Japanese Encephalitis Vaccine Market Size & CAGR, 2018 VS 2022 VS 2029

7.3 By Application, Global Live Attenuated Japanese Encephalitis Vaccine Revenue, 2018-2029

7.4 By Application, Global Live Attenuated Japanese Encephalitis Vaccine Sales Volume, 2018-2029

7.5 By Application, Global Live Attenuated Japanese Encephalitis Vaccine Price, 2018-2029

8 Sales Sights by Region

8.1 By Region, Global Live Attenuated Japanese Encephalitis Vaccine Market Size, 2018 VS 2022 VS 2029

8.2 By Region, Global Live Attenuated Japanese Encephalitis Vaccine Revenue, 2018-2029

8.3 By Region, Global Live Attenuated Japanese Encephalitis Vaccine Sales Volume, 2018-2029

8.4 North America

8.4.1 North America Live Attenuated Japanese Encephalitis Vaccine Market Size & Forecasts, 2018-2029

8.4.2 By Country, North America Live Attenuated Japanese Encephalitis Vaccine Market Size Market Share

8.5 Europe

8.5.1 Europe Live Attenuated Japanese Encephalitis Vaccine Market Size & Forecasts, 2018-2029

8.5.2 By Country, Europe Live Attenuated Japanese Encephalitis Vaccine Market Size Market Share

8.6 Asia Pacific

8.6.1 Asia Pacific Live Attenuated Japanese Encephalitis Vaccine Market Size & Forecasts, 2018-2029

8.6.2 By Country/Region, Asia Pacific Live Attenuated Japanese Encephalitis Vaccine Market Size Market Share

8.7 South America

8.7.1 South America Live Attenuated Japanese Encephalitis Vaccine Market Size & Forecasts, 2018-2029

8.7.2 By Country, South America Live Attenuated Japanese Encephalitis Vaccine Market Size Market Share

8.8 Middle East & Africa

9 Sales Sights by Country Level

9.1 By Country, Global Live Attenuated Japanese Encephalitis Vaccine Market Size & CAGR，2018 VS 2022 VS 2029

9.2 By Country, Global Live Attenuated Japanese Encephalitis Vaccine Revenue, 2018-2029

9.3 By Country, Global Live Attenuated Japanese Encephalitis Vaccine Sales Volume, 2018-2029

9.4 U.S.

9.4.1 U.S. Live Attenuated Japanese Encephalitis Vaccine Market Size, 2018-2029

9.4.2 By Company, U.S. Live Attenuated Japanese Encephalitis Vaccine Sales Volume Market Share, 2022

9.4.3 By Type, U.S. Live Attenuated Japanese Encephalitis Vaccine Market Size, Share, 2022 VS 2029

9.4.4 By Application, U.S. Live Attenuated Japanese Encephalitis Vaccine Market Size, Share, 2022 VS 2029

9.5 Europe

9.5.1 Europe Live Attenuated Japanese Encephalitis Vaccine Market Size, 2018-2029

9.5.2 By Company, Europe Live Attenuated Japanese Encephalitis Vaccine Sales Volume Market Share, 2022

9.5.3 By Type, Europe Live Attenuated Japanese Encephalitis Vaccine Market Size, Share, 2022 VS 2029

9.5.4 By Application, Europe Live Attenuated Japanese Encephalitis Vaccine Market Size, Share, 2022 VS 2029

9.6 China

9.6.1 China Live Attenuated Japanese Encephalitis Vaccine Market Size, 2018-2029

9.6.2 By Company, China Live Attenuated Japanese Encephalitis Vaccine Sales Volume Market Share, 2022

9.6.3 By Type, China Live Attenuated Japanese Encephalitis Vaccine Market Size, Share, 2022 VS 2029

9.6.4 By Application, China Live Attenuated Japanese Encephalitis Vaccine Market Size, Share, 2022 VS 2029

9.7 Japan

9.7.1 Japan Live Attenuated Japanese Encephalitis Vaccine Market Size, 2018-2029

9.7.2 By Company, Japan Live Attenuated Japanese Encephalitis Vaccine Sales Volume Market Share, 2022

9.7.3 By Type, Japan Live Attenuated Japanese Encephalitis Vaccine Market Size, Share, 2022 VS 2029

9.7.4 By Application, Japan Live Attenuated Japanese Encephalitis Vaccine Market Size, Share, 2022 VS 2029

9.8 South Korea

9.8.1 South Korea Live Attenuated Japanese Encephalitis Vaccine Market Size, 2018-2029

9.8.2 By Company, South Korea Live Attenuated Japanese Encephalitis Vaccine Sales Volume Market Share, 2022

9.8.3 By Type, South Korea Live Attenuated Japanese Encephalitis Vaccine Market Size, Share, 2022 VS 2029

9.8.4 By Application, South Korea Live Attenuated Japanese Encephalitis Vaccine Market Size, Share, 2022 VS 2029

9.9 Southeast Asia

9.9.1 Southeast Asia Live Attenuated Japanese Encephalitis Vaccine Market Size, 2018-2029

9.9.2 By Company, Southeast Asia Live Attenuated Japanese Encephalitis Vaccine Sales Volume Market Share, 2022

9.9.3 By Type, Southeast Asia Live Attenuated Japanese Encephalitis Vaccine Market Size, Share, 2022 VS 2029

9.9.4 By Application, Southeast Asia Live Attenuated Japanese Encephalitis Vaccine Market Size, Share, 2022 VS 2029

9.10 India

9.10.1 India Live Attenuated Japanese Encephalitis Vaccine Market Size, 2018-2029

9.10.2 By Company, India Live Attenuated Japanese Encephalitis Vaccine Sales Volume Market Share, 2022

9.10.3 By Type, India Live Attenuated Japanese Encephalitis Vaccine Market Size, Share, 2022 VS 2029

9.10.4 By Application, India Live Attenuated Japanese Encephalitis Vaccine Market Size, Share, 2022 VS 2029

9.11 Middle East & Asia

9.11.1 Middle East & Asia Live Attenuated Japanese Encephalitis Vaccine Market Size, 2018-2029

9.11.2 By Company, Middle East & Asia Live Attenuated Japanese Encephalitis Vaccine Sales Volume Market Share, 2022

9.11.3 By Type, Middle East & Asia Live Attenuated Japanese Encephalitis Vaccine Market Size, Share, 2022 VS 2029

9.11.4 By Application, Middle East & Asia Live Attenuated Japanese Encephalitis Vaccine Market Size, Share, 2022 VS 2029

10 Manufacturers Profile

10.1 Novartis

10.1.1 Novartis Company Information, Head Office, Market Area and Industry Position

10.1.2 Novartis Live Attenuated Japanese Encephalitis Vaccine Models, Specifications and Application

10.1.3 Novartis Live Attenuated Japanese Encephalitis Vaccine Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.1.4 Novartis Company Profile and Main Business

10.1.5 Novartis Recent Developments

10.2 Sanofi

10.2.1 Sanofi Company Information, Head Office, Market Area and Industry Position

10.2.2 Sanofi Live Attenuated Japanese Encephalitis Vaccine Models, Specifications and Application

10.2.3 Sanofi Live Attenuated Japanese Encephalitis Vaccine Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.2.4 Sanofi Company Profile and Main Business

10.2.5 Sanofi Recent Developments

10.3 Chengdu Institute of Biological Products

10.3.1 Chengdu Institute of Biological Products Company Information, Head Office, Market Area and Industry Position

10.3.2 Chengdu Institute of Biological Products Live Attenuated Japanese Encephalitis Vaccine Models, Specifications and Application

10.3.3 Chengdu Institute of Biological Products Live Attenuated Japanese Encephalitis Vaccine Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.3.4 Chengdu Institute of Biological Products Company Profile and Main Business

10.3.5 Chengdu Institute of Biological Products Recent Developments

10.4 Wuhan Institute of Biological Products

10.4.1 Wuhan Institute of Biological Products Company Information, Head Office, Market Area and Industry Position

10.4.2 Wuhan Institute of Biological Products Live Attenuated Japanese Encephalitis Vaccine Models, Specifications and Application

10.4.3 Wuhan Institute of Biological Products Live Attenuated Japanese Encephalitis Vaccine Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.4.4 Wuhan Institute of Biological Products Company Profile and Main Business

10.4.5 Wuhan Institute of Biological Products Recent Developments

10.5 Lanzhou Institute of Biological Products

10.5.1 Lanzhou Institute of Biological Products Company Information, Head Office, Market Area and Industry Position

10.5.2 Lanzhou Institute of Biological Products Live Attenuated Japanese Encephalitis Vaccine Models, Specifications and Application

10.5.3 Lanzhou Institute of Biological Products Live Attenuated Japanese Encephalitis Vaccine Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.5.4 Lanzhou Institute of Biological Products Company Profile and Main Business

10.5.5 Lanzhou Institute of Biological Products Recent Developments

10.6 Beijing Temple of Heaven Biological Products

10.6.1 Beijing Temple of Heaven Biological Products Company Information, Head Office, Market Area and Industry Position

10.6.2 Beijing Temple of Heaven Biological Products Live Attenuated Japanese Encephalitis Vaccine Models, Specifications and Application

10.6.3 Beijing Temple of Heaven Biological Products Live Attenuated Japanese Encephalitis Vaccine Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.6.4 Beijing Temple of Heaven Biological Products Company Profile and Main Business

10.6.5 Beijing Temple of Heaven Biological Products Recent Developments

10.7 Valneva

10.7.1 Valneva Company Information, Head Office, Market Area and Industry Position

10.7.2 Valneva Live Attenuated Japanese Encephalitis Vaccine Models, Specifications and Application

10.7.3 Valneva Live Attenuated Japanese Encephalitis Vaccine Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.7.4 Valneva Company Profile and Main Business

10.7.5 Valneva Recent Developments

10.8 Bharat Biotech

10.8.1 Bharat Biotech Company Information, Head Office, Market Area and Industry Position

10.8.2 Bharat Biotech Live Attenuated Japanese Encephalitis Vaccine Models, Specifications and Application

10.8.3 Bharat Biotech Live Attenuated Japanese Encephalitis Vaccine Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.8.4 Bharat Biotech Company Profile and Main Business

10.8.5 Bharat Biotech Recent Developments

10.9 Cheng Da Biology

10.9.1 Cheng Da Biology Company Information, Head Office, Market Area and Industry Position

10.9.2 Cheng Da Biology Live Attenuated Japanese Encephalitis Vaccine Models, Specifications and Application

10.9.3 Cheng Da Biology Live Attenuated Japanese Encephalitis Vaccine Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.9.4 Cheng Da Biology Company Profile and Main Business

10.9.5 Cheng Da Biology Recent Developments

10.10 Biocelect Pty Ltd

10.10.1 Biocelect Pty Ltd Company Information, Head Office, Market Area and Industry Position

10.10.2 Biocelect Pty Ltd Live Attenuated Japanese Encephalitis Vaccine Models, Specifications and Application

10.10.3 Biocelect Pty Ltd Live Attenuated Japanese Encephalitis Vaccine Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.10.4 Biocelect Pty Ltd Company Profile and Main Business

10.10.5 Biocelect Pty Ltd Recent Developments

10.11 Glovax Co., Ltd.

10.11.1 Glovax Co., Ltd. Company Information, Head Office, Market Area and Industry Position

10.11.2 Glovax Co., Ltd. Live Attenuated Japanese Encephalitis Vaccine Models, Specifications and Application

10.11.3 Glovax Co., Ltd. Live Attenuated Japanese Encephalitis Vaccine Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.11.4 Glovax Co., Ltd. Company Profile and Main Business

10.11.5 Glovax Co., Ltd. Recent Developments

11 Conclusion

12 Appendix

12.1 Research Methodology

12.2 Data Source

12.2.1 Secondary Sources

12.2.2 Primary Sources

12.3 Market Estimation Model

12.4 Disclaimer

Table 1. Live Attenuated Japanese Encephalitis Vaccine Market Size & CAGR: China VS Global, 2018-2029, US$ Million

Table 2. Live Attenuated Japanese Encephalitis Vaccine Market Restraints

Table 3. Live Attenuated Japanese Encephalitis Vaccine Market Trends

Table 4. Live Attenuated Japanese Encephalitis Vaccine Industry Policy

Table 5. Global Live Attenuated Japanese Encephalitis Vaccine Revenue by Company, 2018-2023, US$ million

Table 6. Global Live Attenuated Japanese Encephalitis Vaccine Revenue Market Share by Company, 2018-2023

Table 7. Global Live Attenuated Japanese Encephalitis Vaccine Sales Volume by Company, 2018-2023, (K Units)

Table 8. Global Live Attenuated Japanese Encephalitis Vaccine Sales Volume Market Share by Company, 2018-2023

Table 9. Global Live Attenuated Japanese Encephalitis Vaccine Price by Company, 2018-2023, (US$/Unit)

Table 10. Global Live Attenuated Japanese Encephalitis Vaccine Manufacturers Market Concentration Ratio (CR3 and HHI)

Table 11. Global Live Attenuated Japanese Encephalitis Vaccine Mergers & Acquisitions, Expansion Plans

Table 12. Global Live Attenuated Japanese Encephalitis Vaccine Manufacturers Product Type

Table 13. China Live Attenuated Japanese Encephalitis Vaccine Revenue by Company, 2018-2023, US$ million

Table 14. China Live Attenuated Japanese Encephalitis Vaccine Revenue Market Share by Company, 2018-2023

Table 15. China Live Attenuated Japanese Encephalitis Vaccine Sales Volume by Company, 2018-2023, (K Units)

Table 16. China Live Attenuated Japanese Encephalitis Vaccine Sales Volume Market Share by Company, 2018-2023

Table 17. China Market, Live Attenuated Japanese Encephalitis Vaccine Production, Sales, Import and Export, 2018-2029, (K Units)

Table 18. China Live Attenuated Japanese Encephalitis Vaccine Import & Export Trends

Table 19. Main Sources of China Live Attenuated Japanese Encephalitis Vaccine Import

Table 20. Export Destination of China Live Attenuated Japanese Encephalitis Vaccine

Table 21. Global Headquarters and Manufacturing Base of Live Attenuated Japanese Encephalitis Vaccine Manufacturers

Table 22. Global Major Manufacturers, Live Attenuated Japanese Encephalitis Vaccine Capacity Expansion and Future Plans

Table 23. Global Live Attenuated Japanese Encephalitis Vaccine Production & Forecast by Region, 2018 VS 2022 VS 2029, (K Units)

Table 24. Global Live Attenuated Japanese Encephalitis Vaccine Production by Region, 2018-2023, (K Units)

Table 25. Global Live Attenuated Japanese Encephalitis Vaccine Production Forecast by Region, 2023-2029, (K Units)

Table 26. Global Key Players of Live Attenuated Japanese Encephalitis Vaccine Upstream (Raw Materials)

Table 27. Global Live Attenuated Japanese Encephalitis Vaccine Typical Customers

Table 28. Live Attenuated Japanese Encephalitis Vaccine Typical Distributors

Table 29. By Type, Global Live Attenuated Japanese Encephalitis Vaccine Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 30. By Application, Global Live Attenuated Japanese Encephalitis Vaccine Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 31. By Region, Global Live Attenuated Japanese Encephalitis Vaccine Market Size, 2018 VS 2022 VS 2029, US$ Million

Table 32. By Region, Global Live Attenuated Japanese Encephalitis Vaccine Revenue, 2018-2029, US$ Million

Table 33. By Region, Global Live Attenuated Japanese Encephalitis Vaccine Sales Volume, 2018-2029, (K Units)

Table 34. By Country, Global Live Attenuated Japanese Encephalitis Vaccine Revenue & CAGR，2018 VS 2022 VS 2029, US$ Million

Table 35. By Country, Global Live Attenuated Japanese Encephalitis Vaccine Revenue, 2018-2029, US$ Million

Table 36. By Country, Global Live Attenuated Japanese Encephalitis Vaccine Revenue Market Share, 2018-2029

Table 37. By Country, Global Live Attenuated Japanese Encephalitis Vaccine Sales Volume, 2018-2029, (K Units)

Table 38. By Country, Global Live Attenuated Japanese Encephalitis Vaccine Sales Volume Market Share, 2018-2029

Table 39. Novartis Company Information, Head Office, Market Area and Industry Position

Table 40. Novartis Live Attenuated Japanese Encephalitis Vaccine Models, Specifications and Application

Table 41. Novartis Live Attenuated Japanese Encephalitis Vaccine Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 42. Novartis Company Profile and Main Business

Table 43. Novartis Recent Developments

Table 44. Sanofi Company Information, Head Office, Market Area and Industry Position

Table 45. Sanofi Live Attenuated Japanese Encephalitis Vaccine Models, Specifications and Application

Table 46. Sanofi Live Attenuated Japanese Encephalitis Vaccine Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 47. Sanofi Company Profile and Main Business

Table 48. Sanofi Recent Developments

Table 49. Chengdu Institute of Biological Products Company Information, Head Office, Market Area and Industry Position

Table 50. Chengdu Institute of Biological Products Live Attenuated Japanese Encephalitis Vaccine Models, Specifications and Application

Table 51. Chengdu Institute of Biological Products Live Attenuated Japanese Encephalitis Vaccine Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 52. Chengdu Institute of Biological Products Company Profile and Main Business

Table 53. Chengdu Institute of Biological Products Recent Developments

Table 54. Wuhan Institute of Biological Products Company Information, Head Office, Market Area and Industry Position

Table 55. Wuhan Institute of Biological Products Live Attenuated Japanese Encephalitis Vaccine Models, Specifications and Application

Table 56. Wuhan Institute of Biological Products Live Attenuated Japanese Encephalitis Vaccine Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 57. Wuhan Institute of Biological Products Company Profile and Main Business

Table 58. Wuhan Institute of Biological Products Recent Developments

Table 59. Lanzhou Institute of Biological Products Company Information, Head Office, Market Area and Industry Position

Table 60. Lanzhou Institute of Biological Products Live Attenuated Japanese Encephalitis Vaccine Models, Specifications and Application

Table 61. Lanzhou Institute of Biological Products Live Attenuated Japanese Encephalitis Vaccine Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 62. Lanzhou Institute of Biological Products Company Profile and Main Business

Table 63. Lanzhou Institute of Biological Products Recent Developments

Table 64. Beijing Temple of Heaven Biological Products Company Information, Head Office, Market Area and Industry Position

Table 65. Beijing Temple of Heaven Biological Products Live Attenuated Japanese Encephalitis Vaccine Models, Specifications and Application

Table 66. Beijing Temple of Heaven Biological Products Live Attenuated Japanese Encephalitis Vaccine Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 67. Beijing Temple of Heaven Biological Products Company Profile and Main Business

Table 68. Beijing Temple of Heaven Biological Products Recent Developments

Table 69. Valneva Company Information, Head Office, Market Area and Industry Position

Table 70. Valneva Live Attenuated Japanese Encephalitis Vaccine Models, Specifications and Application

Table 71. Valneva Live Attenuated Japanese Encephalitis Vaccine Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 72. Valneva Company Profile and Main Business

Table 73. Valneva Recent Developments

Table 74. Bharat Biotech Company Information, Head Office, Market Area and Industry Position

Table 75. Bharat Biotech Live Attenuated Japanese Encephalitis Vaccine Models, Specifications and Application

Table 76. Bharat Biotech Live Attenuated Japanese Encephalitis Vaccine Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 77. Bharat Biotech Company Profile and Main Business

Table 78. Bharat Biotech Recent Developments

Table 79. Cheng Da Biology Company Information, Head Office, Market Area and Industry Position

Table 80. Cheng Da Biology Live Attenuated Japanese Encephalitis Vaccine Models, Specifications and Application

Table 81. Cheng Da Biology Live Attenuated Japanese Encephalitis Vaccine Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 82. Cheng Da Biology Company Profile and Main Business

Table 83. Cheng Da Biology Recent Developments

Table 84. Biocelect Pty Ltd Company Information, Head Office, Market Area and Industry Position

Table 85. Biocelect Pty Ltd Live Attenuated Japanese Encephalitis Vaccine Models, Specifications and Application

Table 86. Biocelect Pty Ltd Live Attenuated Japanese Encephalitis Vaccine Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 87. Biocelect Pty Ltd Company Profile and Main Business

Table 88. Biocelect Pty Ltd Recent Developments

Table 89. Glovax Co., Ltd. Company Information, Head Office, Market Area and Industry Position

Table 90. Glovax Co., Ltd. Live Attenuated Japanese Encephalitis Vaccine Models, Specifications and Application

Table 91. Glovax Co., Ltd. Live Attenuated Japanese Encephalitis Vaccine Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 92. Glovax Co., Ltd. Company Profile and Main Business

Table 93. Glovax Co., Ltd. Recent Developments

List of Figure

Figure 1. Live Attenuated Japanese Encephalitis Vaccine Picture

Figure 2. By Revenue, Global Live Attenuated Japanese Encephalitis Vaccine Market Size and Forecast, 2018-2029, US$ Million

Figure 3. By Sales Volume, Global Live Attenuated Japanese Encephalitis Vaccine Market Size and Forecast, 2018-2029, (K Units)

Figure 4. Global Live Attenuated Japanese Encephalitis Vaccine Price Trend, 2018-2029, (US$/Unit)

Figure 5. By Revenue, China Live Attenuated Japanese Encephalitis Vaccine Market Size and Forecast, 2018-2029, US$ million

Figure 6. By Sales Volume, China Live Attenuated Japanese Encephalitis Vaccine Market Size and Forecast, 2018-2029, (K Units)

Figure 7. China Live Attenuated Japanese Encephalitis Vaccine Price Trend, 2018-2029 (US$/Unit)

Figure 8. By Revenue, China Live Attenuated Japanese Encephalitis Vaccine Share of Global Market, 2018-2029

Figure 9. By Sales Volume, China Live Attenuated Japanese Encephalitis Vaccine Share of Global Market, 2018-2029

Figure 10. Global Live Attenuated Japanese Encephalitis Vaccine Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 11. Global Live Attenuated Japanese Encephalitis Vaccine Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2022

Figure 12. China Live Attenuated Japanese Encephalitis Vaccine Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 13. China Live Attenuated Japanese Encephalitis Vaccine Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 14. China Live Attenuated Japanese Encephalitis Vaccine Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2018-2023

Figure 15. Chinese Local Players, Proportion of Live Attenuated Japanese Encephalitis Vaccine Domestic VS Export, 2022

Figure 16. Global Live Attenuated Japanese Encephalitis Vaccine Capacity, Production and Capacity Utilization, 2018-2029

Figure 17. Global Live Attenuated Japanese Encephalitis Vaccine Capacity Market Share by Region, 2022 VS 2029

Figure 18. Global Live Attenuated Japanese Encephalitis Vaccine Production Market Share & Forecast by Region, 2018-2029

Figure 19. Live Attenuated Japanese Encephalitis Vaccine Industry Chain

Figure 20. Live Attenuated Japanese Encephalitis Vaccine Procurement Model

Figure 21. Live Attenuated Japanese Encephalitis Vaccine Sales Model

Figure 22. Live Attenuated Japanese Encephalitis Vaccine Sales Channels, Direct Sales and Distribution

Figure 23. 0.5ml

Figure 24. 1ml

Figure 25. 2.5ml

Figure 26. By Type, Global Live Attenuated Japanese Encephalitis Vaccine Revenue, 2018-2029, US$ Million

Figure 27. By Type, Global Live Attenuated Japanese Encephalitis Vaccine Revenue Market Share, 2018-2029

Figure 28. By Type, Global Live Attenuated Japanese Encephalitis Vaccine Sales Volume, 2018-2029, (K Units)

Figure 29. By Type, Global Live Attenuated Japanese Encephalitis Vaccine Sales Volume Market Share, 2018-2029

Figure 30. By Type, Global Live Attenuated Japanese Encephalitis Vaccine Price, 2018-2029, (US$/Unit)

Figure 31. Hospital

Figure 32. Clinic

Figure 33. By Application, Global Live Attenuated Japanese Encephalitis Vaccine Revenue, 2018-2029, US$ Million

Figure 34. By Application, Global Live Attenuated Japanese Encephalitis Vaccine Revenue Market Share, 2018-2029

Figure 35. By Application, Global Live Attenuated Japanese Encephalitis Vaccine Sales Volume, 2018-2029, (K Units)

Figure 36. By Application, Global Live Attenuated Japanese Encephalitis Vaccine Sales Volume Market Share, 2018-2029

Figure 37. By Application, Global Live Attenuated Japanese Encephalitis Vaccine Price, 2018-2029, (US$/Unit)

Figure 38. By Region, Global Live Attenuated Japanese Encephalitis Vaccine Revenue Market Share, 2018-2029

Figure 39. By Region, Global Live Attenuated Japanese Encephalitis Vaccine Sales Volume Market Share, 2018-2029

Figure 40. North America Live Attenuated Japanese Encephalitis Vaccine Revenue & Forecasts, 2018-2029, US$ Million

Figure 41. By Country, North America Live Attenuated Japanese Encephalitis Vaccine Revenue Market Share, 2022

Figure 42. Europe Live Attenuated Japanese Encephalitis Vaccine Revenue & Forecasts, 2018-2029, US$ Million

Figure 43. By Country, Europe Live Attenuated Japanese Encephalitis Vaccine Revenue Market Share, 2022

Figure 44. Asia Pacific Live Attenuated Japanese Encephalitis Vaccine Revenue & Forecasts, 2018-2029, US$ Million

Figure 45. By Country/Region, Asia Pacific Live Attenuated Japanese Encephalitis Vaccine Revenue Market Share, 2022

Figure 46. South America Live Attenuated Japanese Encephalitis Vaccine Revenue & Forecasts, 2018-2029, US$ Million

Figure 47. By Country, South America Live Attenuated Japanese Encephalitis Vaccine Revenue Market Share, 2022

Figure 48. Middle East & Africa Live Attenuated Japanese Encephalitis Vaccine Revenue & Forecasts, 2018-2029, US$ Million

Figure 49. U.S. Live Attenuated Japanese Encephalitis Vaccine Sales Volume, 2018-2029, (K Units)

Figure 50. By Company, U.S. Live Attenuated Japanese Encephalitis Vaccine Market Share, 2022

Figure 51. By Type, U.S. Live Attenuated Japanese Encephalitis Vaccine Sales Volume Market Share, 2022 VS 2029

Figure 52. By Application, U.S. Live Attenuated Japanese Encephalitis Vaccine Sales Volume Market Share, 2022 VS 2029

Figure 53. Europe Live Attenuated Japanese Encephalitis Vaccine Sales Volume, 2018-2029, (K Units)

Figure 54. By Company, Europe Live Attenuated Japanese Encephalitis Vaccine Market Share, 2022

Figure 55. By Type, Europe Live Attenuated Japanese Encephalitis Vaccine Sales Volume Market Share, 2022 VS 2029

Figure 56. By Application, Europe Live Attenuated Japanese Encephalitis Vaccine Sales Volume Market Share, 2022 VS 2029

Figure 57. China Live Attenuated Japanese Encephalitis Vaccine Sales Volume, 2018-2029, (K Units)

Figure 58. By Company, China Live Attenuated Japanese Encephalitis Vaccine Market Share, 2022

Figure 59. By Type, China Live Attenuated Japanese Encephalitis Vaccine Sales Volume Market Share, 2022 VS 2029

Figure 60. By Application, China Live Attenuated Japanese Encephalitis Vaccine Sales Volume Market Share, 2022 VS 2029

Figure 61. Japan Live Attenuated Japanese Encephalitis Vaccine Sales Volume, 2018-2029, (K Units)

Figure 62. By Company, Japan Live Attenuated Japanese Encephalitis Vaccine Market Share, 2022

Figure 63. By Type, Japan Live Attenuated Japanese Encephalitis Vaccine Sales Volume Market Share, 2022 VS 2029

Figure 64. By Application, Japan Live Attenuated Japanese Encephalitis Vaccine Sales Volume Market Share, 2022 VS 2029

Figure 65. South Korea Live Attenuated Japanese Encephalitis Vaccine Sales Volume, 2018-2029, (K Units)

Figure 66. By Company, South Korea Live Attenuated Japanese Encephalitis Vaccine Market Share, 2022

Figure 67. By Type, South Korea Live Attenuated Japanese Encephalitis Vaccine Sales Volume Market Share, 2022 VS 2029

Figure 68. By Application, South Korea Live Attenuated Japanese Encephalitis Vaccine Sales Volume Market Share, 2022 VS 2029

Figure 69. Southeast Asia Live Attenuated Japanese Encephalitis Vaccine Sales Volume, 2018-2029, (K Units)

Figure 70. By Company, Southeast Asia Live Attenuated Japanese Encephalitis Vaccine Market Share, 2022

Figure 71. By Type, Southeast Asia Live Attenuated Japanese Encephalitis Vaccine Sales Volume Market Share, 2022 VS 2029

Figure 72. By Application, Southeast Asia Live Attenuated Japanese Encephalitis Vaccine Sales Volume Market Share, 2022 VS 2029

Figure 73. India Live Attenuated Japanese Encephalitis Vaccine Sales Volume, 2018-2029, (K Units)

Figure 74. By Company, India Live Attenuated Japanese Encephalitis Vaccine Market Share, 2022

Figure 75. By Type, India Live Attenuated Japanese Encephalitis Vaccine Sales Volume Market Share, 2022 VS 2029

Figure 76. By Application, India Live Attenuated Japanese Encephalitis Vaccine Sales Volume Market Share, 2022 VS 2029

Figure 77. Middle East & Asia Live Attenuated Japanese Encephalitis Vaccine Sales Volume, 2018-2029, (K Units)

Figure 78. By Company, Middle East & Asia Live Attenuated Japanese Encephalitis Vaccine Market Share, 2022

Figure 79. By Type, Middle East & Asia Live Attenuated Japanese Encephalitis Vaccine Sales Volume Market Share, 2022 VS 2029

Figure 80. By Application, Middle East & Asia Live Attenuated Japanese Encephalitis Vaccine Sales Volume Market Share, 2022 VS 2029

Figure 81. Research Methodology

Figure 82. Breakdown of Primary Interviews

Figure 83. Bottom-up Approaches

Figure 84. Top-down Approaches

Methodology/Research Approach

This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.

Research Programs/Design

Historical Data (2015-2019)	Industry Trends Competitive Landscape By Company Expansion Mergers and Acquisitions Market Segment by Type by Application By Regions/ Geography	Value Status and Outlook Value for Major Players Market Share Growth Rate Present Situation Analysis Value Market Share Growth Rate Present Situation Analysis
Influencing Factors	Market Environment Government Policy Technological Changes Market Risks	Market Drivers Growing Demand of Downstream Reduction in Cost
Market Forecast (2021-2026)	Overall Size by Type by Application By Regions/Geography	Key Data (Value) Market Share Growth Rate CAGR (2021-2026)

Market Size Estimation

Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).

The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.

Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.

All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report

The following figure shows an illustrative representation of the overall market size estimation process used for this study.

Market Breakdown and Data Triangulation

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.

Data Source

Secondary Sources

Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.

Market Size	Segmental value Geographic Penetration Product Adoption Rate for Different market	Journals, Websites, and Press Releases Annual Reports and SEC Filings Company Websites and Press Releases Public and Paid Databases Market Intellix Data Repository
Market Position of Top Company	Product Financials Geographic value Mix Total Company value Business/Segmental value Mix
Qualitative Analysis	Influence Factors Market Potential Market Risks and Opportunities Industry Trends Geographical Features Government Policies	Company Websites and Press Releases Public and Paid Databases Annual Reports Industry Associations Market Intellix Data Repository

Primary Sources

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.

Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.

Key Executives Interviewed

Key Data Information from Primary Sources

Primary Sources	Parameters	Key Data
Market Segments(by Application, by Type)	Value by Type Status and Forecast Value by Application Value by Regions, Status and Forecast (2021-2026)	Value Market Share by Type Value Growth Rate by Type Value by Application Percentage and Growth Rate by Application Value Growth Rate and Market Share by Regions Market Size Status and Forecast (2021-2026)
Total Market	Overall Size, Status and Forecast	Market Size Status and Forecast (2021-2026)